The Efficacy of Cardiac Contractility Modulation for Treating Patients with Heart Failure

Area of Science:

• Cardiology
• Medical Devices

Background:

• Heart failure (HF) remains a significant cause of mortality and morbidity globally.
• Despite therapeutic advancements, HF management presents ongoing challenges.

Purpose of the Study:

• To evaluate the efficacy of cardiac contractility modulation (CCM) in Chinese patients diagnosed with heart failure.
• To assess CCM's impact on cardiac function and ventricular remodeling.

Main Methods:

• A retrospective study involving six Chinese patients with NYHA class II or III heart failure.
• CCM implantation was performed, with assessments conducted before and after 12 months of treatment.
• Key outcome measures included left ventricular ejection fraction (LVEF), left ventricular end-diastolic dimension (LVEDD), and left atrium diameter (LAD).

Main Results:

• Significant improvement in LVEF from 27% to 39.67% after 12 months of CCM therapy.
• Reduction in LVEDD from 70.33 mm to 64.83 mm, indicating reversed ventricular remodeling.
• Decrease in LAD from 52.83 mm to 47.00 mm, with all patients achieving NYHA functional class II.

Conclusions:

• CCM therapy demonstrates potential in enhancing cardiac functional status in heart failure patients.
• The findings suggest CCM can improve LVEF and promote reverse ventricular remodeling.
• This study provides preliminary evidence for CCM's effectiveness in a Chinese patient cohort.